AHA 2020 Archives - Medical Conferences

Home > Cardiology > AHA 2020

Read the full Report (pdf)

American Heart Association
3–17 November 2020

Featured articles

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

AHA 2020

24 February, 2021 07:59

AHA 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

AHA 2020

18 November, 2020 12:39

Online First

COVID-19 and Influenza

Fewer CV complications than expected in AHA COVID-19 Registry

Presented By

Prof. James de Lemos, University of Texas Southwestern Medical Center, USA

Trial

AHA COVID-19 CVD Registry

Conference

AHA 2020

17 February, 2021 13:39

Worse COVID-19 outcomes in younger obese patients

Presented By

Dr Nicholas Hendren, University of Texas Southwestern, USA

Trial

AHA COVID-19 CVD Registry

Conference

AHA 2020

17 February, 2021 13:28

Effects of CVD in hospitalised COVID-19 patients

Presented By

Prof. Ann Marie Navar, University of Texas Southwestern, USA

Conference

AHA 2020

17 February, 2021 13:22

Meta-analyses: ACEI/ARB and COVID-19

Presented By

Dr Yujiro Yokoyama, St. Luke's University Hospital

Conference

AHA 2020

17 February, 2021 13:18

Unfavourable outcomes for COVID-19 patients with AF and atrial flutter

Presented By

Dr Zaniar Ghazizadeh, Brigham and Women’s Hospital, USA

Trial

Yale Cardiovascular COVID Registry

Conference

AHA 2020

17 February, 2021 12:08

High-dose influenza vaccine in patients with CVD

Presented By

Prof. Orly Vardeny, University of Minnesota Medical School, USA

Trial

Phase 4, INVESTED

Conference

AHA 2020

17 February, 2021 10:36

Atrial Fibrillation

Vitamin D or omega 3 fatty acids do not prevent AF

Presented By

Prof. Christine Albert, Cedars-Sinai Medical Center, USA

Trial

VITAL Rhythm

Conference

AHA 2020

17 February, 2021 14:19

Active screening for AF improves clinical outcomes

Presented By

Dr Steven Steinhubl, Scripps Research Translational Institute, USA

Trial

mSToPS

Conference

AHA 2020

17 February, 2021 14:16

AF screening in older adults at primary care visits

Presented By

Dr Steven Lubitz, Massachusetts General Hospital, USA

Trial

VITAL-AF

Conference

AHA 2020

17 February, 2021 14:06

CVD Risk Reduction

Clever trial design gets patients back on statins: the SAMSON trial

Presented By

Dr James Howard, Imperial College London, UK

Trial

SAMSON

Conference

AHA 2020

17 February, 2021 15:10

Polypill plus aspirin reduces cardiovascular events

Presented By

Prof. Salim Yusuf, Population Health Research Institute, Canada

Trial

TIPS-3

Conference

AHA 2020

17 February, 2021 14:58

Lowering LDL cholesterol in older patients is beneficial

Presented By

Dr Baris Gencer, Brigham and Women’s Hospital, USA

Conference

AHA 2020

17 February, 2021 14:54

No CV benefit from omega 3 in high-risk patients

Presented By

Prof. Michael Lincoff, Cleveland Clinic, USA

Trial

STRENGTH

Conference

AHA 2020

17 February, 2021 14:44

Safety and efficacy of inclisiran for hypercholesterolemia

Presented By

Prof. R. Scott Wright, Mayo Clinic, USA

Trial

Phase 3, ORION

Conference

AHA 2020

17 February, 2021 14:37

Remote risk management programme effective and efficient

Presented By

Prof. Benjamin Scirica, Brigham and Women’s Hospital, USA

Conference

AHA 2020

17 February, 2021 14:31

Healthy lifestyle lowers mortality irrespective of medication burden

Presented By

Dr Neil Kelly, Weill Cornell University, USA

Trial

REGARDS

Conference

AHA 2020

17 February, 2021 14:24

Heart Failure

Omecamtiv mecarbil improves outcomes in HFrEF-patients

Presented By

Prof. John Teerlink, University of California, San Francisco, USA

Trial

GALACTIC-HF

Conference

AHA 2020

18 February, 2021 10:25

IV iron reduces HF hospitalisation

Presented By

Prof. Piotr Ponikowski, Wroclaw Medical University, Poland

Trial

AFFIRM-AHF

Conference

AHA 2020

18 February, 2021 10:22

Dapagliflozin reduces renal risk independent of CV disease status

Presented By

Prof. John McMurray, University of Glasgow, Scotland

Trial

DAPA-CKD

Conference

AHA 2020

18 February, 2021 10:18

“Strongly consider an SGLT2-inhibitor in most T2DM patients”

Presented By

Prof. Deepak Bhatt, Brigham and Women’s Hospital, USA

Trial

Phase 3, SOLOIST-WHF; SCORED

Conference

AHA 2020

18 February, 2021 10:14

Additional HFrEF education and patient-engagement tools

Presented By

Prof. Larry Allen, University of Colorado School of Medicine, USA

Trial

EPIC-HF

Conference

AHA 2020

18 February, 2021 10:09

Acute Coronary Syndrome

No benefit from omega-3 fatty acids after recent MI

Presented By

Dr Are Kalstad, Oslo University Hospital, Norway

Trial

OMEMI

Conference

AHA 2020

18 February, 2021 10:34

PIONEER III trial: Drug-eluting stents comparable

Presented By

Prof. Alexandra Lansky, Yale School of Medicine, USA

Trial

PIONEER III

Conference

AHA 2020

18 February, 2021 10:30

Coronary and Valve Disease

Extra imaging reveals cause of MINOCA in women

Presented By

Prof. Harmony Reynolds, New York University Grossman School of Medicine, USA

Trial

HARP-MINOCA

Conference

AHA 2020

18 February, 2021 10:50

Ticagrelor not superior to clopidogrel after elective PCI

Presented By

Prof. Johanne Silvain, Sorbonne University, France

Trial

Phase 3, ALPHEUS

Conference

AHA 2020

18 February, 2021 10:43

Stroke

Ticagrelor/aspirin reduces stroke risk in patients with ipsilateral cervicocranial plaque

Presented By

Prof. Pierre Amarenco, Paris University, France

Trial

THALES

Conference

AHA 2020

18 February, 2021 11:01

AF monitoring following cardiovascular surgery

Presented By

Prof. Subodh Verma, University of Toronto, Canada)

Trial

SEARCH-AF

Conference

AHA 2020

18 February, 2021 10:54

Miscellaneous

PAD: Rivaroxaban reduces VTE risk after revascularisation

Presented By

Dr Connie Hess; Prof. Judith Hsia

Trial

VOYAGER PAD

Conference

AHA 2020

18 February, 2021 11:45

Sotatercept: potential new treatment option for PAH

Presented By

Prof. Vallerie McLaughlin, University of Michigan, USA

Trial

Phase 2, PULSAR

Conference

AHA 2020

18 February, 2021 11:37

Finerenone lowers CV events in diabetic CKD patients

Presented By

Prof. Gerasimos Filippatos, National and Kapodistrian University of Athens, Greece

Trial

Phase 3, FIDELIO-DKD

Conference

AHA 2020

18 February, 2021 11:33

Mavacamten effective in obstructive hypertrophic cardiomyopathy

Presented By

Dr Sheila Hegde, Brigham and Women’s Hospital, USA

Trial

Phase 3, EXPLORER-HCM

Conference

AHA 2020

18 February, 2021 11:28

Children exposed to tobacco smoke have worse heart function as adults

Presented By

Dr Chigozie Ezegbe, University of Tasmania, Australia

Conference

AHA 2020

18 February, 2021 11:25

Transgender people have unaddressed heart disease risks

Presented By

Dr Kara Denby, Cleveland Clinic, USA

Conference

AHA 2020

18 February, 2021 11:23

Rilonacept reduces risk of pericarditis recurrence

Presented By

Dr Alan Klein, Cleveland Clinic, USA

Trial

Phase 3, RHAPSODY

Conference

AHA 2020

18 February, 2021 11:18

Intensive blood pressure lowering benefits older adults

Presented By

Prof. William Cushman, University of Tennessee Health Science, USA

Trial

SPRINT

Conference

AHA 2020

18 February, 2021 11:13

Dobutamine versus milrinone in cardiogenic shock

Trial

Capital Do-Re-Mi

Conference

AHA 2020

18 February, 2021 11:10

Longer chest compression pause worsens outcomes after paediatric IHCA

Presented By

Dr Kasper Glerup Lauridsen, Aarhus University, Denmark

Conference

AHA 2020

18 February, 2021 11:06

Featured articles

CONTENTS

Online First

COVID-19 and Influenza

Atrial Fibrillation

CVD Risk Reduction

Heart Failure

Acute Coronary Syndrome

Coronary and Valve Disease

Stroke

Miscellaneous